None listed
Conditions
Interventions
None listed
Sponsors
Institute of Teaching and Research in Ayurveda
Eligibility
Inclusion criteria
Inclusion criteria: Male participants aged from 21 to 40 years Normal semen parameters according to WHO 2021 No significant systemic or reproductive anatomical abnormalities confirmed through hematological serological and urine investigations and USG of the abdomen pelvis and scrotum Willing to provide written informed consent to participate in the study Eligible for Snehapana and Shodhana
Exclusion criteria
Exclusion criteria: Abnormal semen analysis parameters as per WHO 2021 thresholds Presence of significant systemic illnesses such as diabetes mellitus cardiovascular diseases or hepatic renal dysfunction History of varicocele, hydrocele or any reproductive tract inection. History of surgical interventions in the reproductive system. Participants undergoing concurrent treatment for infertility or on hormonal therapy. Known hypersensitivity or contraindications to any components used in the study treatment. Presence of significant abnormalities detected in hematological serological or urine investigations. Participants not willing to provide consent.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Improvement in Semen Quality based on sperm count, motility, morphology and volume. Reduction in Sperm DNA Fragmentation Index (DFI) Timepoint: After treatment - after 3 months of internal medication Follow-up - follow-up will occur 21 days after treatment completion | — |
Secondary
| Measure | Time frame |
|---|---|
| Optimization of Hormonal Levels of FSH, LH and Testosterone. Enhancement in International Index of Erectile Function (IIEF) scores after the intervention compared to baseline. Conception Success Timepoint: After treatment - after the administration of the therapeutic intervention, will be 3 months and 15 days. The first follow-up will occur 21 days after treatment completion, during which repeat semen analysis to observe sustained or progressive improvements. A second follow-up will be scheduled 6 months post-treatment to evaluate the feasibility of conception success. | — |
Countries
India
Contacts
Public ContactDr Mandip Goyal
Institute of Teaching and Research in Ayurveda
Outcome results
None listed